FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3167304832> ?p ?o ?g. }

• W3167304832 abstract "Abstract Background Despite being in clinical remission, many people with inflammatory bowel disease (IBD) live with fatigue, chronic abdominal pain and bowel urgency or incontinence that limit their quality of life. We aim to test the effectiveness of an online self-management programme (BOOST), developed using cognitive behavioural principles and a theoretically informed logic model, and delivered with facilitator support. Primary research question In people with IBD who report symptoms of fatigue, pain or urgency and express a desire for intervention, does a facilitator-supported tailored (to patient needs) online self-management programme for fatigue, pain and faecal urgency/incontinence improve IBD-related quality of life (measured using the UK-IBDQ) and global rating of symptom relief (0–10 scale) compared with care as usual? Methods A pragmatic two-arm, parallel group randomised controlled trial (RCT), of a 12-session facilitator-supported online cognitive behavioural self-management programme versus care as usual to manage symptoms of fatigue, pain and faecal urgency/incontinence in IBD. Patients will be recruited through a previous large-scale survey of unselected people with inflammatory bowel disease. The UK Inflammatory Bowel Disease Questionnaire and global rating of symptom relief at 6 months are the co-primary outcomes, with multiple secondary outcomes measured also at 6 and 12 months post randomisation to assess maintenance. The RCT has an embedded pilot study, health economics evaluation and process evaluation. We will randomise 680 patients, 340 in each group. Demographic characteristics and outcome measures will be presented for both study groups at baseline. The UK-IBDQ and global rating of symptom relief at 6 and 12 months post randomisation will be compared between the study groups. Discussion The BOOST online self-management programme for people with IBD-related symptoms of fatigue, pain and urgency has been designed to be easily scalable and implemented. If it is shown to improve patients’ quality of life, this trial will enable clinicians and patients to make informed management decisions. This is the first trial, to our knowledge, focused on multiple symptoms prioritised by both people with IBD and health professionals. Trial registration ISRCTN71618461. Registered on 9 September 2019." @default.
• W3167304832 created "2021-06-22" @default.
• W3167304832 creator A5002262418 @default.
• W3167304832 creator A5003860013 @default.
• W3167304832 creator A5005903809 @default.
• W3167304832 creator A5006661722 @default.
• W3167304832 creator A5014296377 @default.
• W3167304832 creator A5027578432 @default.
• W3167304832 creator A5038929444 @default.
• W3167304832 creator A5038967944 @default.
• W3167304832 creator A5040981628 @default.
• W3167304832 creator A5048089533 @default.
• W3167304832 creator A5054250912 @default.
• W3167304832 creator A5054678271 @default.
• W3167304832 creator A5059384559 @default.
• W3167304832 creator A5063565006 @default.
• W3167304832 creator A5071122268 @default.
• W3167304832 creator A5074731920 @default.
• W3167304832 creator A5075382347 @default.
• W3167304832 creator A5075617051 @default.
• W3167304832 creator A5085823951 @default.
• W3167304832 date "2021-08-03" @default.
• W3167304832 modified "2023-10-17" @default.
• W3167304832 title "Supported online self-management versus care as usual for symptoms of fatigue, pain and urgency/incontinence in adults with inflammatory bowel disease (IBD-BOOST): study protocol for a randomised controlled trial" @default.
• W3167304832 cites W1559421953 @default.
• W3167304832 cites W1669870 @default.
• W3167304832 cites W1677400045 @default.
• W3167304832 cites W1765812672 @default.
• W3167304832 cites W1808761756 @default.
• W3167304832 cites W1896805399 @default.
• W3167304832 cites W1909684250 @default.
• W3167304832 cites W1966189788 @default.
• W3167304832 cites W1979730300 @default.
• W3167304832 cites W1990166011 @default.
• W3167304832 cites W2001049433 @default.
• W3167304832 cites W2026222517 @default.
• W3167304832 cites W2030691009 @default.
• W3167304832 cites W2030894553 @default.
• W3167304832 cites W2034783885 @default.
• W3167304832 cites W2052776464 @default.
• W3167304832 cites W2053281833 @default.
• W3167304832 cites W2059273665 @default.
• W3167304832 cites W2063802149 @default.
• W3167304832 cites W2064044020 @default.
• W3167304832 cites W2068642589 @default.
• W3167304832 cites W2083683937 @default.
• W3167304832 cites W2085001923 @default.
• W3167304832 cites W2090605054 @default.
• W3167304832 cites W2094083485 @default.
• W3167304832 cites W2095809030 @default.
• W3167304832 cites W2098473606 @default.
• W3167304832 cites W2099697117 @default.
• W3167304832 cites W2108882655 @default.
• W3167304832 cites W2112157563 @default.
• W3167304832 cites W2115984595 @default.
• W3167304832 cites W2122883493 @default.
• W3167304832 cites W2123485165 @default.
• W3167304832 cites W2125070112 @default.
• W3167304832 cites W2126236881 @default.
• W3167304832 cites W2132322340 @default.
• W3167304832 cites W2135961894 @default.
• W3167304832 cites W2145475034 @default.
• W3167304832 cites W2146252824 @default.
• W3167304832 cites W2157387867 @default.
• W3167304832 cites W2162544110 @default.
• W3167304832 cites W2169434152 @default.
• W3167304832 cites W2170478958 @default.
• W3167304832 cites W2200319253 @default.
• W3167304832 cites W2298239037 @default.
• W3167304832 cites W2314867160 @default.
• W3167304832 cites W2317616155 @default.
• W3167304832 cites W2483286263 @default.
• W3167304832 cites W2516321587 @default.
• W3167304832 cites W2611722398 @default.
• W3167304832 cites W2613630341 @default.
• W3167304832 cites W2799759998 @default.
• W3167304832 cites W2938697113 @default.
• W3167304832 cites W2970086534 @default.
• W3167304832 cites W2971693121 @default.
• W3167304832 cites W2992163887 @default.
• W3167304832 cites W4236722063 @default.
• W3167304832 cites W4249909743 @default.
• W3167304832 doi "https://doi.org/10.1186/s13063-021-05466-4" @default.
• W3167304832 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8329619" @default.
• W3167304832 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34344432" @default.
• W3167304832 hasPublicationYear "2021" @default.
• W3167304832 type Work @default.
• W3167304832 sameAs 3167304832 @default.
• W3167304832 citedByCount "10" @default.
• W3167304832 countsByYear W31673048322021 @default.
• W3167304832 countsByYear W31673048322022 @default.
• W3167304832 countsByYear W31673048322023 @default.
• W3167304832 crossrefType "journal-article" @default.
• W3167304832 hasAuthorship W3167304832A5002262418 @default.
• W3167304832 hasAuthorship W3167304832A5003860013 @default.
• W3167304832 hasAuthorship W3167304832A5005903809 @default.
• W3167304832 hasAuthorship W3167304832A5006661722 @default.
• W3167304832 hasAuthorship W3167304832A5014296377 @default.
• W3167304832 hasAuthorship W3167304832A5027578432 @default.
• W3167304832 hasAuthorship W3167304832A5038929444 @default.

• next